- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2007
- Public Summary Document (PSD) March 2007 PBAC Meeting - PDF
Ranibizumab – March 2007
Ranibizumab, solution for intravitreal injection, 3.0 mg/0.3 mL, Lucentis®, March 2007
Last updated
29 June 2007
